SELECTED QUARTERLY FINANCIAL DATA (Tables)
|12 Months Ended|
Dec. 31, 2018
|SELECTED QUARTERLY FINANCIAL DATA|
|Schedule of selected quarterly financial data||
*Gross profit is computed as Net product sales less Cost of product sales. Prior to the FDA approval, manufacturing and related costs were charged to research and development expense. Therefore, these costs were not capitalized and as a result, are not fully reflected in the costs of sales during the periods disclosed above.
Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.
Reference 1: http://www.xbrl.org/2003/role/presentationRef